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Abstract The form of protein phosphatase-1 associated with 
hepatic glycogen (PP1G) was purified to near homogeneity from 
rat liver by affinity chromatography on microcystin-Sepharose 
and gel-filtration. The enzyme is a heterodimer consisting of the 
catalytic subunit of PP1 (the a and 13 isoforms) complexed to a 
33 kDa glycogen-binding (GO subunit. The GL subunit binds 
phosphorylase a with high affinity, and is responsible for the 
enhanced ephosphorylation of glycogen synthase by PP1G and 
its allosteric inhibition by phosphorylase a. 
Key words: Microcystin; Protein phosphatase; Glycogen; 
Phosphorylase; Glycogen synthase 
I. Introduction 
The subcellular location, substrate specificity and regulation 
of protein phosphatase-1 (PP1) is determined by its interaction 
with targetting subunits (reviewed in [1]). Two targetted forms 
of PP1 have been isolated from striated muscles, termed PP1G 
[2] and PP1M [3,4], in which the catalytic subunit is complexed 
to G and M subunits, respectively. The G subunit directs PPI 
to both glycogen-protein particles [2,5] and the membranes of 
the sarcoplasmic reticulum [6], facilitating the dephosphoryla- 
tion of glycogen metabolising enzymes [7] and SR proteins [8], 
respectively, while the M subunit targets PP1 to myofibrils, 
greatly enhancing the dephosphorylation f myosin and sup- 
pressing activity towards the glycogen-metabolising e zymes 
[3]. PP1 interacts with at least two proteins in nuclei, an inhib- 
itor NIPP1 [9] and the Saccharomyces cerevisiae protein sds22 +, 
which is essential for exit from mitosis [10]. PP1G can be acti- 
vated or inhibited in striated muscles depending on whether it 
is phosphorylated by an insulin-stimulated protein kinase [11] 
or by cyclic AMP-dependent protein kinase [1,12-14], while the 
ability of NIPP1 to inhibit PP1 is prevented by its phosphoryl- 
ation in vitro [15]. These observations suggest that the modifi- 
cation of targetting subunits may be a common device for 
regulating different forms of PP1 selectively. 
The targetting subunits of PP1 are tissue specific. The M 
subunit of striated muscle is structurally [4] and functionally [3] 
distinct from that found in smooth muscle [16,17]. The former 
enhances the dephosphorylation f skeletal muscle myosin 
much more than the dephosphorylation f smooth muscle 
myosin, while the latter stimulates the dephosphorylation f 
smooth muscle myosin, but not skeletal muscle myosin [16]. 
The hepatic glycogen-binding subunit (GL) is also distinct from 
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that present in striated muscles (GM). Hepatic PP1G has greatly 
enhanced activity towards glycogen synthase, while activity 
towards phosphorylase is strongly suppressed. Thus the glyco- 
gen synthase phosphatase (GSP):phosphorylase phosphat- 
ase(PhP) activity ratio of hepatic PP1G is far higher than that 
of muscle PP1G or the PP1 catalytic subunit [18]. Hepatic 
PP1G is also remarkable in that its GSP activity is inhibited by 
the active form of phosphorylase (phosphorylase a) at a con- 
centration (IC50 = 5 nM) 1000-fold lower than the Km for 
phosphorylase a as a substrate [19], suggesting that inhibition 
occurs by an allosteric mechanism. The GSP activity of hepatic 
PP1G is also inhibited by physiological concentrations of cal- 
cium ions [20]. Hepatic PP1G is inhibited by phosphorylase a 
[21] or Ca 2÷ [20] much more potently in the presence of glyco- 
gen. 
Several years ago, hepatic PP1G was purified by a procedure 
involving chromatography on cyclodextrin-Sepharose [22], the 
final preparation containing four silver staining bands of 160, 
54, 36 and 32 kDa. The 160 kDa component co-migrated with 
the GM subunit on SDS-PAGE and was suggested to be GL, 
while the 36 and 32 kDa species were though to represent native 
and proteolysed forms of PP1. Peptide sequencing revealed that 
the 54 kDa band was c~-amylase [22]. We have recently devel- 
oped a microcystin-Sepharose affinity column for purifying 
protein serine/threonine phosphatases and exploited it to iso- 
late PP1M from skeletal muscle [4]. Here we use this method 
to isolate hepatic PP1G and identify the Ge subunit as a 33 kDa 
protein. 
2. Materials and methods 
2.1. Materials 
PP1M from chicken gizzard [17] was provided by Miss D. Johnson, 
PPIG from rabbit skeletal muscle [2] and bacterially expressed PPly 
[22a] by Dr. D. Alessi, phosphorylase b, phosphorylase kinase and 
glycogen synthase by Miss F. Douglas and glycogen synthase kinase-3 
by Dr. C. Sutherland in this laboratory. Microcystin (MC)-LR was 
purified and used to synthesise aminoethanethiol-microcystin-LR- 
Sepharose (hereafter called MC-Sepharose) as in [4]. ~251-Labelled MC- 
YR (a MC variant provided by Dr. P. Thiel, Research Institute for 
Nutritonal Diseases, Tygerberg, South Africa) was prepared as in [4]. 
Superose 12 (HR 10/30) was from Pharmacia (Milton Keynes, UK), 
alkylated trypsin from Promega (Southampton, UK), endoproteinase 
Lys-C and anti-digoxygenin a tibodies from Boehringer (Lewes, UK) 
and alkylated Triton X-100 from Calbiochem (Nottingham, UK). 
Other chemicals were from BDH Chemicals (Poole, UK) or Sigma 
(Poole, UK). 
2.2. Preparation of phosphorylated proteins and phosphatase assays 
32P-Labelled phosphorylase a (containing 1.0 mol phosphate per mol 
subunit) was prepared by phosphorylation with phosphorylase kinase 
[23], and thiophosphorylase a was obtained in an identical manner 
except hat unlabelled adenosine 5' [y-thio]triphosphate replaced ATP. 
3ZP-Labelled glycogen synthase was phosphorylated at site 2 to 0,8 
mol/mol subunit with trypsin-activated phosphorylase kinase [24] or at 
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site 3 to 1.5 mol/mol subunit with GSK3 [25]. The deposphorylation f 
phosphorylase a (10/tM) and glycogen synthase (1 pM) was carried out 
as in [23] and one unit of activity (U) was that amount which catalysed 
the release of 1 pmol of phosphate from each substrate in 1 min. 
2.3. Isolation of hepatic glycogen-prote& particles 
These were isolated from the livers of adult Wistar rats or fed New 
Zealand White rabbits according to [21]. After the final centrifugation 
at 100,000 × g, the microsomal pellet overlaying the glycogen-protein 
pellet was removed by vortexing ently with buffer followed by aspira- 
tion. Glycogen-protein particles were also isolated from the livers of 
300 g Wistar rats that had been deprived of food for 16 h and injected 
with glucagon (0.35 mg) 30 min prior to removal of the livers to ensure 
total depletion of glycogen [26]. In this procedure, livers were processed 
as for fed rats up to and including high speed centrifugation. The 
100,000 x g supernatant was then made 5 mg/ml in glycogen and again 
centrifuged for 90 min at 100,000 × g. 
2.4. Purification of rat liver PPIG 
MC-Sepharose (0.5 ml, containing 0.15 mg of MC) was added to the 
glycogen-protein pellet from one rat liver suspended in 3 ml of 50 mM 
Tris-HCl, pH 7.0, 0.1 mM EGTA, 5% (v/v) glycerol, 0.1% (v/v) 2- 
mercaptoethanol (buffer A) plus the proteinase inhibitors 1 mM ben- 
zamidine, 0.5 mM phenylmethanesulphonyl fluoride, 0.5 mM to- 
sylphenylchloromethyl ketone and 4/.tg/ml leupeptin. After mixing for 
30 min at 4°C, the suspension was poured into a small column and the 
matrix washed with buffer A containing 0.5 M NaC1. When the protein 
concentration of the eluate was -< 0.005 mg/ml, one void volume of 
buffer A containing 3 M sodium isothiocyanate was passed through the 
column and the flow stopped for 30 min. PP1 was then eluted with 
buffer A containing 3 M sodium isothiocyanate and the active fractions 
dialysed overnight against buffer A. 
2.5. Identification of the PPl-binding subunit using [z:5I]microcystin- 
YR-PP1 and digoxygenin-PP1 as probes 
The PPI 7/isoform (30pg) was labelled with [~25I]MC-YR as in [4] and 
bovine serum albumin included at 1 mg/ml. The solution was reduced 
from 1 ml to 50pl by ultrafiltration through a Centricon 30 membrane, 
diluted to 1.5 ml with 25 mM Tris-HCl (pH 7.5) containing 250 mM 
NaCI (buffer B), reconcentrated to 50 pl, and this procedure repeated 
twice to remove MC not coupled to PP1. PP1 ~' (30 pg) was also labelled 
with the ester of digoxygenin-3-O-methylcarbonyl-e-aminocaproic- 
acid-N-hydroxysuccinimide (Boehringer) and separated from excess 
reagent according to the instructions of the manufacturer. 
Protein samples containing hepatic PP1G were separated by SDS- 
PAGE, transferred to nitrocellulose membranes, and non-specific sites 
blocked by incubation for 16 h at ambient temperature with 5% (w/v) 
skimmed milk powder in 25 mM Tris-HC1 (pH 7.5) and 500 mM NaC1. 
The nitrocellulose membranes were incubated for 4 h at ambient tem- 
perature with either digoxygenin-labelled PP17 or [125I]MC-labelled 
PPIy diluted to 2.5 ,ug/ml in buffer B plus 1 mg/ml bovine serum 
albumin, then washed several times with buffer B over a 3 h period to 
remove unbound probe. Blots were either autoradiographed ([~25I]MC- 
PPIy) or probed for 45 min with anti-digoxygenin a tibodies conju- 
gated with peroxidase (0.03 U/ml in buffer B plus 1 mg/ml bovine serum 
albumin), then washed for 3 h with buffer B and visualised with the 
enhanced chemiluminescence system (Amersham International, Bucks, 
UK). 
2.6. Identification of the G L subunit as a phosphorylase a-binding 
protein 
This was carried out as in section 2.5 except hat after SDS-PAGE 
and transfer to nitrocellulose, hepatic PP1G was probed with 10/lg/ml 
32P-labelled phosphorylase a (106 cpm/nmol) [23], washed three times in 
25 mM Tris-HC1, pH 7.5 (30 min per wash), and autoradiographed. 
2. Z Amino acid sequencing 
The Coomassie blue-stained subunits of hepatic PP1G (about 4 pg) 
were excised from SDS-PAGE gels, washed five times with water and 
brought o near dryness in a vacuum concentrator. The gel pieces were 
suspended in 0.3 ml of 50 mM Tris-HCl, pH 8, 0.01% (v/v) alkylated 
Triton X-100 and digested for 24 h with 1/~g of alkylated trypsin, or 
suspended in 0.3 ml of 50 mM Tris-HC1, pH 8.5, 1 mM EDTA, 0.01% 
(v/v) alkylated Triton X-100 and digested for 48 h with Lys-C endopro- 
teinase, 1.25 ,ug of proteinase being added at time zero and after 24 h. 
The supernatants were removed and the gel pieces extracted for a 
further 5 h with 0.2 ml of buffer. The combined supernatants from each 
digest were either chromatographed on Aquapore RP-300 (I00 x 2.1 
mm) or on a Vydac Ci8 column (150 x 2.1 mm) which were connected 
to an Applied Biosystems 140B HPLC system equilibrated in0.1% (v/v) 
trifluoroacetic a id. Both columns were developed with linear acetoni- 
trile gradients in 0.1% trifluoroacetic acid with an increase in acetoni- 
trile concentration of 0.5% per min. Peptides detected by absorbance 
at 214 nm were collected and analysed on an Applied Biosystems 476A 
Sequencer. 
3. Results 
3.1. Purification of  glycogen-associated PP1 from rat liver 
Glycogen-protein particles isolated from the livers of fed rats 
contain four major proteins of 160, 97, 86 and 70 kDa, corre- 
sponding to glycogen debranching enzyme, glycogen 
phosphorylase, glycogen synthase and glycogen branching en- 
zyme, respectively (Fig. 1, lane 1), but the concentrat ion of 
hepatic PP1G at this step is too low to be detected by staining 
with Coomassie blue. PP1G associated with liver glycogen- 
protein particles was retained by MC-Sepharose and eluted 
with 3 M isothiocyanate, as reported for PP1M from skeletal 
muscle myofibrils [4]. The PP1 activity which eluted in the first 
two fractions (Pool 1, Fig. 2) had a PhP/GSP activity ratio of 
15.4 + 1.6 (+ S.E.M. for four preparations) imilar to the value 
of 14.7 + 0.6 (+S.E.M. for four preparations) in glycogen 
protein particles. The GSP activity of Pool 1 was inhibited by 
phosphorylase a with an IC50 (11 nM) similar to that of PP IG  
in glycogen-protein particles (8 nM) (Fig. 3). These properties 
indicated that the PP1 in Pool 1 contained the subunit(s) which 
confers the distinctive properties of hepatic PP1G. Pool 1, 
which contained 0.5% of the protein applied to MC-Sepharose, 
was concentrated and analysed by SDS-PAGE. Debranching 
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Fig. 1. SDS-10% polyacrylamide gel-electrophoresis of different frac- 
tions obtained uring the purification of hepatic PP1G. The gels were 
stained with Coomassie blue and migration is from top to bottom. The 
positions of debranching enzyme (D), phosphorylase (P), glycogen syn- 
thase (S), branching enzyme (B) and the standard marker proteins 
myosin (205 kDa), phosphorylase (97 kDa), bovine serum albumin (66 
kDa), ovalbumin (43 kDa) and carbonic anhydrase (29 kDa) are indi- 
cated. Protein phosphatase-1 (PP1) is eluted as a doublet at 38/37 kDa 
corresponding to the ~ and fl isozymes, respectively (see section 3.2) and 
its glycogen-binding (GL) subunit is eluted at 33 kDa. Lane 1, glycogen- 
protein particles from fed rats; lane 2, Pool I from MC-Sepharose 
(Fig. 2); lane 3, Pool 2 from MC-Sepharose; lane 4, PP1G further 
purified from Pool 1 by gel-filtration on Superose 12. 
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Fig. 2, Affinity chromatography of rat liver glycogen particles on mi- 
crocystin-Sepharose. Glycogen-protein particles isolated from the liver 
of a fed rat were chromatographed on MC-Sepharose and PPI eluted 
with buffer A plus 3 M isothiocyanate (see section 2.4). Fractions of 
1.0 ml were collected and assayed for phosphorylase phosphatase (PhP) 
activity (e) and for glycogen synthase phosphatase (GSP) activity (o) 
with glycogen synthase labelled at site 2. The PhP/GSP activity ratio 
is shown by the filled triangles. Fractions (1 and 2) with a low PhP/GSP 
activity ratio and fractions (4-7) with a high PhP/GSP ratio were pooled 
separately and termed Pool 1 and Pool 2, respectively. 
enzyme, phosphorylase, glycogen synthase and branching en- 
zyme were still present, but there was a striking enrichment of 
a 33 kDa protein and a 38/37 kDa doublet when compared to 
glycogen-protein particles (compare lanes 1 and 2 in Fig. 1), 
The 38 and 37 kDa proteins were present in similar amounts 
in every preparation and continued to co-purify with the 33 
kDa band, and with hepatic PP1G, through gel filtration, the 
higher molecular mass contaminants being largely removed at 
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Fig. 3. The sensitivity of the glycogen synthase phosphatase activity of 
hepatic PP1G to thiophosphorylase  is unaffected by affinity purifica- 
tion on microcystin-Sepharose. Glycogen synthase phosphatase (GSP) 
activity was assayed in the presence of 5 mg/ml glycogen with glycogen 
synthase labelled at site 3, using hepatic glycogen-protein particles 
from a fed rat liver (closed triangles), Pool 1 from MC-Sepharose ( ) 
and Pool 2 from MC-Sepharose (©) (see legend to Fig. 2). 
this stage (Fig. 1, lane 4). PP1G eluted from Superose 12 as a 
broad peak centred at 60 kDa (data not shown). 
3.2. Identification of the 38/37 kDa doublet as the o~ and fl 
isoJbrrns of PP1 and the 33 kDa band as the GL subunit 
The cyclic heptapeptide MC binds covalently to active PPI 
[4] and radiolabelled MC-PP1 complexes can therefore be iden- 
tified after SDS-PAGE and autoradiography. [12Sl]MC-YR la- 
belled the 38/37 kDa doublet in Pool 1 or in glycogen-protein 
particles (Fig. 4), indicating that these bands correspond to the 
PP1 catalytic subunit. To establish this point definitively, the 
38/37 kDa doublet was excised from the gel, digested with 
trypsin and several of the peptides generated were purified and 
sequenced. All the peptides analysed were derived from PP1. 
However, one peptide (IVQMTEAEVR) was unique to PPlfl 
(residues 26-35) while another isolated in similar amounts 
(YGQFSGLNPGGR) was specific to PPI~ (residues 306-317) 
[27]. Immunoblotting with isoform-specific antibodies revealed 
that the apparent molecular masses of PPIc~ and PPlfl 
on SDS-PAGE are 38 kDa and 37 kDa, respectively 
[28], suggesting that the 38 kDa and 37 kDa bands in hepat- 
ic PP1G might correspond to PPlc~ and PPIfl, respectively. 
Consistent with this interpretation, the catalytic subunit 
of PP1G from skeletal muscle, which is PPlfl [29], co-mi- 
grated with the lower (37 kDa) band of the doublet (data not 
shown). 
The 33 kDa band was not labelled with [~z~I]MC-YR, indicat- 
ing that it was not the active PP1 fragment which can be gener- 
ated by proteolysis from the native 37 kDa species [15]. How- 
ever, the 33 kDa band was the only protein that became labelled 
when Pool 1 was subjected to SDS-PAGE and blotted with 
[~25I]MC-YR-PP1z (Fig. 5A, lane 1). The specificity of this 
probe for PPl-binding subunits was established by the finding 
that it labels only the 130 kDa PPl-binding M subunit of 
smooth muscle PP1M (Fig. 5A, lane 2), and not the 37 kDa 
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Fig. 4. Labelling of the protein phosphatase-1 catalytic subunit with 
['2SI]microcystin-YR. Fractions containing PP1 were incubated for 2 h 
(lane 2) and 16 h (lanes 1, 3 and 4) with [~2Sl]MC-YR as in [4], denatured 
in SDS, subjected to electrophoresis ona 10% polyacrylamide g land 
autoradiographed. Lane 1, bacterially expressed PPIy; lanes 2 and 3, 
Pool 1 from MC-Sepharose (Fig. 2); lane 4, hepatic glycogen-protein 
particle preparation from the liver of a fed rat. The marker proteins are 
as in Fig. 1, 
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Fig. 5. Identification of the GL subunit using [t2~l]microcystin-YR-PP17, digoxygenin PP1T and 32p-labelled phosphorylase a as probes. The 
PPl-containing fractions from Fig. 2 were denatured in SDS, electrophoresed on 10% polyacrylamide g ls, transferred to nitrocellulose and blotted 
with the labelled PP1 probes (see section 2.5) and 32p-labelled phosphorylase a (see section 2.6). (A) Pool 1 from chromatography of rat hepatic 
glycogen protein particles on MC-Sepharose (lane 1) and purified PP1M from chicken gizzard smooth muscle (lane 2) were blotted with ['25I]MC- 
YR-PP17. (B) Glycogen-protein particles isolated from the liver of a fed rabbit (lane 1), a fasted rat (lane 2) and a fed rat (lane 3), and Pool 1 from 
MC-Sepharose (lane 4) were probed with digoxygenin PP17. (C) Pool 1 from chromatography of rat hepatic glycogen-protein particles on 
MC-Sepharose was probed with 32p-labelled phosphorylase a.The molecular mass standards are as in Fig. 1 and the positions of the GL subunit 
of hepatic PPIG and the M subunit of smooth muscle PP1M are marked. 
subunit (i.e. PP1 itself) or the 20 kDa subunit that are also 
present in this enzyme [16]. The 33 kDa protein in Pool 1 was 
also recognised specifically by a second probe, digoxygenin- 
PPly (Fig. 5B, lane 4), previously used to identify the PP1- 
binding subunit of smooth muscle PP1M [16]. Digoxygenin 
PPI7 not only recognised the 33 kDa protein specifically in 
Pool 1 (Fig. 5B, lane 4), but also in glycogen-protein particles 
from rabbit (Fig. 5B, lane 1) and rat (Fig. 5B, lanes 2 and 3) 
liver. Moreover, the 33 kDa band in hepatic PPIG was recog- 
nised specifically with a 32p-labelled phosphorylase a probe 
(Fig. 5C), indicating that it is a high affinity phosphorylase 
a-binding protein. The specificity of the phosphorylase a probe 
was established by the finding that it did not label the PP1 
catalytic subunit, the M subunit of smooth muscle PP1M, the 
major glycogen-metabolising e zymes present in the glycogen- 
protein particles, or the molecular mass standards run on the 
same SDS-PAGE gel (data not shown). 
The 33 kDa band was digested with Lys-C endoproteinase 
and the resulting peptides were purified and sequenced. Two 
Lys-C peptides RVSFADNQGLALTMVK and VQNLAFEK 
were very similar to residues 65-80 (RVSFADNFGFNLVS- 
VK) and residues 150-157 (VLNISFEK), respectively, of the 
GM subunit of skeletal muscle PPI~ [30]. 
The later eluting fractions (4~7) from MC-Sepharose (Pool 
2) had a 7- to 10-fold higher PhP/GSP activity ratio than Pool 
1 (Fig. 2), and the GSP activity of Pool 2 was only inhibited by 
phosphorylase a very weakly (Fig. 3). Pool 2 was largely the 
38/37 kDa doublet and contained only traces of the 33 kDa 
protein (Fig. 1, lane 3). The phosphatase activity in Pool 2 was 
eluted from Superose 12 as a major peak of apparent molecular 
mass 35 kDa (data not shown), indicating that it is largely the 
free catalytic subunit of PPI. 
4. Discussion 
Our results establish that PP1G purified from rat liver is a 
heterodimer composed of the ~ or fl isoform of PP1 complexed 
to a 33 kDa (GL) subunit. These components were greatly 
enriched in Pool 1 from MC-Sepharose (Fig. 1), had a PhP/GSP 
activity ratio and sensitivity to phosphorylase a indistinguish- 
able from hepatic glycogen~rotein particles, and continued to 
co-purify through gel-filtration on Superose 12. The Gr subunit 
was recognised by two PP1 probes and by phosphorylase a 
(Fig. 5) and remained entirely bound to glycogen after incuba- 
tion of hepatic glycogen-protein particles for 10 rain with 1 M 
LiBr, a treatment which released 90% of the glycogen synthase 
phosphatase activity (data not shown). This demonstrates that 
the GL subunit is the glycogen binding component. 
Two peptides from GL were strikingly similar to sequences 
found in the glycogen-binding subunit from skeletal muscle. 
The sequence homologous to residues 150 157 of GM lies 
within the region speculated to correspond to the glycogen- 
binding site (see legend of Fig. 2 in [1]), while the sequence 
highly homologous to residues 65-80 of GM contains the serine 
residue whose phosphorylation of which by cyclic AMP-de- 
pendent protein kinase triggers the dissociation of PP 1 from the 
GM subunit [12]. The latter finding is intriguing because no 
evidence currently exists for a role of phosphorylation i  the 
regulation of hepatic PP1G. 
The small size of the GL subunit was surprising since the 
molecular mass of GM is 124 kDa [30] and the G subunit 
homologue in S. cerevisiae (GAC-1) is an 88 kDa protein [31]. 
However, the 33 kDa protein does not seem to be a proteolytic 
fragment of a larger precursor, because it retains all the known 
properties of the putative GL subunit, and no other PPl-bind- 
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ing protein was detected, even in rat or rabbit glycogen-protein 
particles isolated rapidly at 0~°C in the presence of several 
proteinase inhibitors (Fig. 5B). The 33 kDa protein was also 
present in hepatic glycogen-protein particles isolated according 
to [26] (Fig. 5B, lane 2) which are free of microsomes. This 
eliminates the possibility that the 33 kDa protein is a micro- 
somal PPl-targetting subunit present as a contaminant. It is 
particularly noteworthy that no PPl-binding protein with an 
apparent molecular mass of 160 kDa was detected in g lycoge~ 
protein particles. The 160 kDa protein present in a purified 
preparation of PP1G from rat liver and suggested to be the GL 
subunit in [22] may, therefore, be an impurity (perhaps glyco- 
gen debranching enzyme), while the minor 32 kDa band in this 
preparation may be the GL subunit and not a proteolytic frag- 
ment of PP1. The GL subunit is homologous to the N-terminal 
domain of GM, which is known to contain the binding sites for 
PP1 and for glycogen [32]. It may well be that the GL subunit 
is much smaller than its muscle counterpart because no C- 
terminal SR-binding domain is required (see section 1). De- 
tailed analysis of the structure of GL is in progress. 
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